| Women hoping for a pill helping them with sexual dysfunction will have to wait. The Food and Drug Administration turned down Sprout Pharmaceuticals' application for their sexual-desire drug, saying it only has a mild effect on women, outweighed by the risks of side effects. The drug, flibanserin, acts similarly to an antidepressant by lowering serotonin levels, while boosting dopamine levels. RT's Meghan Lopez takes a look at the drug that would be women's response to Viagra. Find RT America in your area: http://rt.com/where-to-watch/ Or watch us online: http://rt.com/on-air/rt-america-air/ Like us on Facebook http://www.facebook.com/RTAmerica Follow us on Twitter http://twitter.com/RT_America | 
No comments:
Post a Comment